Menu Menu


GLAXF Financials       Clear


GLAXF        0001131399    
Filing Date Form Type Description Document
2021-12-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-21 6-K VIIV HEALTHCARE ANNOUNCES FDA APPROVAL OF APRETUDE View Document
2021-12-20 6-K CONSUMER HEALTHCARE CHAIR DESIGNATE APPOINTED View Document
2021-12-17 6-K XEVUDY APPROVED IN EUROPE TO TREAT COVID-19 View Document
2021-12-15 6-K GSK/SANOFI COVID-19 VACCINE BOOSTER & PH3 UPDATE View Document
2021-12-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-07 6-K MEDICAGO/GSK COVID-19 VACCINE POSITIVE PH3 DATA View Document
2021-12-07 6-K SOTROVIMAB RETAINS ITS ACTIVITY VS OMICRON VARIANT View Document
2021-12-02 6-K SOTROVIMAB RETAINS ITS ACTIVITY VS OMICRON VARIANT View Document
2021-12-01 6-K TOTAL VOTING RIGHTS View Document
2021-11-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-24 6-K GSK PUBLISHES PROVISIONAL 2022 DIVIDEND DATES View Document
2021-11-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-17 6-K NUCALA APPROVED IN EUROPE FOR MORE INDICATIONS View Document
2021-11-15 6-K BLOCK LISTING INTERIM REVIEW View Document
2021-11-12 6-K PHASE III IM ADMINISTRATION DATA FOR SOTROVIMAB View Document
2021-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-05 6-K GSK SHARES POSITIVE PHASE III DATA FOR DAPRODUSTAT View Document
2021-11-01 6-K TOTAL VOTING RIGHTS View Document
2021-10-27 6-K 3RD QUARTER RESULTS View Document
2021-10-27 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-27 6-K DIRECTORATE CHANGE View Document
2021-10-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-01 6-K TOTAL VOTING RIGHTS View Document
2021-09-27 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2021-09-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-20 6-K DIRECTOR DECLARATION View Document
2021-09-16 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-09-16 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-09-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-08 UPLOAD View Document
2021-09-07 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-03 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-01 6-K TOTAL VOTING RIGHTS View Document
2021-08-31 CORRESP View Document
2021-08-31 6-K SK BIO & GSK START PH3 COVID-19 VACCINE TRIAL View Document
2021-08-25 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-18 UPLOAD View Document
2021-08-13 6-K/A DIRECTOR/PDMR SHAREHOLDING - AMENDMENT View Document
2021-08-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-05 6-K BLOCK LISTING APPLICATION View Document
2021-08-02 6-K TOTAL VOTING RIGHTS View Document
2021-07-28 6-K 2ND QUARTER RESULTS View Document
2021-07-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-23 6-K BOARD COMMITTEE CHANGES View Document
2021-07-22 6-K CEO DESIGNATE OF NEW CONSUMER HEALTHCARE COMPANY View Document
2021-07-16 6-K GSK ANNOUNCES DAPRODUSTAT PHASE 3 HEADLINE RESULTS View Document
2021-07-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-12 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2021-07-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-07-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP View Document
2021-07-06 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP View Document
2021-07-02 6-K GSK AND ALECTOR COLLABORATION IN IMMUNO-NEUROLOGY View Document
2021-07-02 6-K ELLIOTT ADVISORS (UK) LETTER TO GSK View Document
2021-07-01 6-K TOTAL VOTING RIGHTS View Document
2021-06-25 11-K ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE View Document
2021-06-25 11-K ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE View Document
2021-06-25 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES View Document
2021-06-23 6-K GSK TO DELIVER STEP-CHANGE IN GROWTH & PERFORMANCE View Document
2021-06-22 6-K VIIV/HALOZYME SIGN EXCLUSIVE LICENSING AGREEMENT View Document
2021-06-17 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES View Document
2021-06-14 6-K GSK AND ITEOS ANNOUNCE COLLABORATION FOR EOS-448 View Document
2021-06-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-06-04 6-K TRC CAPITAL LETTER View Document
2021-06-01 6-K TOTAL VOTING RIGHTS View Document
2021-05-27 SD SD View Document
2021-05-27 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-27 6-K SANOFI AND GSK INITIATE NEW PHASE 3 CLINICAL STUDY View Document
2021-05-27 6-K GSK/VIR SOTROVIMAB FDA EMERGENCY USE AUTHORIZATION View Document
2021-05-25 SC 13D/A AMENDED SCHEDULE 13D View Document
2021-05-24 4 CHANGES IN BENEFICIAL OWNERSHIP View Document
2021-05-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-05-21 6-K GSK/VIR SOTROVIMAB RECEIVES POSITIVE EMA OPINION View Document
2021-05-18 6-K BLOCK LISTING INTERIM REVIEW View Document
2021-05-18 6-K MEDICAGO/GSK COVID-19 VACCINE POSITIVE PH2 RESULTS View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas